-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Enhabit (EHAB) Scheduled to Post Earnings on Tuesday
Enhabit (EHAB) Scheduled to Post Earnings on Tuesday
Enhabit (NYSE:EHAB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, February 14th. Analysts expect Enhabit to post earnings of $0.25 per share for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.
Enhabit Price Performance
Shares of NYSE:EHAB opened at $14.41 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.63. The firm's 50-day moving average is $13.89 and its two-hundred day moving average is $14.22. Enhabit has a 1 year low of $11.65 and a 1 year high of $25.25.
Get Enhabit alerts:Insider Buying and Selling
In related news, Director Jeffrey Bolton purchased 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the completion of the acquisition, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
Institutional Investors Weigh In On Enhabit
A number of hedge funds and other institutional investors have recently bought and sold shares of EHAB. Millennium Management LLC purchased a new position in shares of Enhabit in the second quarter valued at $230,000. Envestnet Asset Management Inc. purchased a new position in shares of Enhabit in the third quarter valued at $143,000. UBS Group AG increased its position in shares of Enhabit by 407,300.0% in the third quarter. UBS Group AG now owns 12,222 shares of the company's stock valued at $171,000 after buying an additional 12,219 shares in the last quarter. Macquarie Group Ltd. purchased a new position in shares of Enhabit in the third quarter valued at $187,000. Finally, Teachers Retirement System of The State of Kentucky purchased a new position in shares of Enhabit in the third quarter valued at $192,000. Institutional investors and hedge funds own 95.55% of the company's stock.Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on EHAB shares. CJS Securities started coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. UBS Group assumed coverage on shares of Enhabit in a research note on Thursday, December 8th. They issued a "sell" rating and a $12.00 price target on the stock. Finally, Credit Suisse Group dropped their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $16.43.
About Enhabit
(Get Rating)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Recommended Stories
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
Enhabit (NYSE:EHAB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, February 14th. Analysts expect Enhabit to post earnings of $0.25 per share for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.
EnHabit(紐約證券交易所代碼：EHAB-GET Rating)計劃在2月14日週二股市收盤後公佈季度收益結果。分析師預計，EnHabit本季度每股收益為0.25美元。有興趣參加公司收益電話會議的個人可以使用此鏈接進行。
Enhabit Price Performance
居住性價比
Shares of NYSE:EHAB opened at $14.41 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.63. The firm's 50-day moving average is $13.89 and its two-hundred day moving average is $14.22. Enhabit has a 1 year low of $11.65 and a 1 year high of $25.25.
紐約證券交易所：Ehab的股票週二開盤報14.41美元。該公司的流動比率為1.50，速動比率為1.50，債務權益比率為0.63。該公司的50日移動均線切入位在13.89美元，200日移動均線切入位在14.22美元。EnHabit的一年低點為11.65美元，一年高位為25.25美元。
Insider Buying and Selling
內幕買賣
In related news, Director Jeffrey Bolton purchased 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the completion of the acquisition, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
在相關新聞中，董事的傑弗裏·波頓在11月9日星期三的一筆交易中購買了2,000股該公司的股票。這隻股票是以每股12.75美元的平均價格購買的，總價值為25,500.00美元。收購完成後，董事現在直接擁有該公司14,597股，價值186,111.75美元。此次收購是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過這個環節.
Institutional Investors Weigh In On Enhabit
機構投資者對EnHabit的看法
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
A number of analysts recently weighed in on EHAB shares. CJS Securities started coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. UBS Group assumed coverage on shares of Enhabit in a research note on Thursday, December 8th. They issued a "sell" rating and a $12.00 price target on the stock. Finally, Credit Suisse Group dropped their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $16.43.
一些分析師最近加入了對Ehab股票的看法。CJS證券於12月13日(星期二)在一份研究報告中開始報道EnHabit的股票。他們為該股設定了“市場表現”評級和18.00美元的目標價。Stifel Nicolaus在12月5日星期一的一份研究報告中假設了對EnHabit股票的報道。他們對該股給予了“買入”評級和17.00美元的目標價。奧本海默在10月13日星期四的一份研究報告中對EnHabit的股票進行了報道。他們對該股給予了“市場表現”的評級。瑞銀集團在12月8日星期四的一份研究報告中對EnHabit的股票進行了報道。他們對該股給予了“賣出”評級和12.00美元的目標價。最後，瑞士信貸集團在11月4日星期五的一份研究報告中將EnHabit的股票目標價從19.00美元下調至15.00美元，並將其股票評級定為“中性”。兩名分析師對該股的評級為賣出，四名分析師給予持有評級，兩名分析師給予該股買入評級。根據MarketBeat.com的數據，該股的共識評級為持有，共識目標價為16.43美元。
About Enhabit
關於居住
(Get Rating)
(獲取評級)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
EnHabit，Inc.在美國提供家庭健康和臨終關懷服務。它的家庭健康服務包括患者教育、疼痛管理、傷口護理和換藥、心臟康復、輸液治療、藥物管理和熟練的觀察和評估服務；治療慢性疾病和狀況的做法，包括糖尿病、高血壓、關節炎、阿爾茨海默病、低視力、椎管狹窄、帕金森病、骨質疏鬆症、複雜傷口護理和慢性疼痛，以及針對糖尿病、充血性心力衰竭、骨科術後手術或損傷和呼吸系統疾病的特定疾病計劃；以及物理、職業和語言治療師提供治療服務。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
- 免費獲取StockNews.com關於EnHabit的研究報告(Ehab)
- 勁量控股公司；失去電力或使購買時間帶電？
- 康明斯能再創新高嗎？
- 如何找到可以投資和交易的細價股
- ONSemi以優異的業績走得更高
- 泰森食品第一季度對史泰博股票意味着什麼
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
接受《居住者日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對EnHabit和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧